BSX ▼ -2.7% - Boston Scientific Corporation $BSX lows continue as trader circulate commentary from FDA regarding recent worldwide product recalls Boston Scientific fell 2.7% today as traders responded to FDA commentary about the company's recent worldwide product recalls. The circulation of regulatory feedback on these recalls among market participants likely intensified concerns about the scope and potential financial impact of the issues. 03-SEP-2026 02:44 PM ET